Skip to main content
. Author manuscript; available in PMC: 2016 Apr 21.
Published in final edited form as: Cell Rep. 2015 Apr 9;11(3):376–389. doi: 10.1016/j.celrep.2015.03.034

Figure 2. A peptide derived from EBOV polymerase co-factor VP35 (NPBP) binds ΔNPNTD with high affinity and specificity, related to Figure S1D, S2, S3, S4 and Table S1.

Figure 2

(A) Domain organization of EBOV VP35, including an oligomerization and IID domains. There is a highly conserved region N-terminal to the oligomerization domain, termed NPBP. (B) Impact of the VP35 N-terminus was evaluated by the Ebola minigenome assay. Ability of either wildtype or mutant VP35 proteins lacking various N-terminal sequences were tested and plotted as normalized minigenome activity, where wildtype VP35 activity was set to 100%. Below representative western blots show similar levels of VP35 protein expression. β-tubulin was used as loading control. (C) Summary of binding measurements by ITC between ΔNPNTD and VP35 N-terminal truncation mutants reveal that residues 20–48 are necessary and sufficient for high affinity binding. n.d., not determined. (D) The structure of the dual-octameric ring of ΔNPNTD in complex with VP35 NPBP peptide in a ribbon representation (left) and in a 90° rotated configuration (right). Each NPBP/ΔNPNTD complex in the asymmetric unit is colored yellow/orange (mol A/mol E), magenta/blue (mol B/mol F), green/purple (mol C/mol G), and cyan/pink (mol D/mol H).